Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

EULAR 2014: Shorten Delay for Access to Rheumatologic Patient Care

Thomas R. Collins  |  Issue: September 2014  |  September 1, 2014

Many studies have found that patients tend to take a wait-and-see approach and think their symptoms will just go away.

Having heard or read that it’s important to act quickly is one of the least common reasons patients see a doctor, Dr. Raza said. “People aren’t aware of rheumatoid arthritis; they aren’t aware of what their symptoms might mean.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Mallen
Dr. Fautrel

Patients’ poor evaluation of their own symptoms is probably the factor that can be most manipulated in order to prompt patients to seek help more quickly, he said. One potential solution would be a public health campaign regarding inflammatory arthritis, but there are significant challenges associated with that. It’s not as simple as telling patients to visit the doctor for joint pain; given how common musculoskeletal symptoms are that could inundate GPs’ offices, he said. Deciding what to tell patients to look for requires more research to identify the constellation of symptoms with the best ability to identify those patients with, or at risk of, RA and to separate them from those with other less urgent musculo­skeletal conditions, Dr. Raza said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Getting patients with new onset RA to consult quickly is a key challenge that we must rise to,” Dr. Raza said. “A public health campaign may well help, but its content should be informed by evidence—what set of symptoms are we going to tell people that they should be looking out for?—and its impact should be formally assessed in the context of carefully designed pilots.”

Beyond broad public awareness campaigns—which might be of questionable value—there are specific opportunities to help patients assess their own symptoms better. Before people actually see a doctor, research has shown they often visit the pharmacy to get over-the-counter drugs and research their symptoms on the Web. Therefore, Dr. Raza said, easy availability of helpful information at the pharmacy might be a useful step, along with sharpening the delivery of information on commonly visited websites.


Thomas R. Collins is a freelance medical writer based in Florida.

Reference

  1. Villeneuve E, Nam J, Bell M, et al. A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis. Ann Rheum Dis. 2013 Jan;72(1):13–22.

Page: 1 2 3 | Single Page
Share: 

Filed under:Axial SpondyloarthritisEULAR/OtherMeeting ReportsPractice SupportQuality Assurance/Improvement Tagged with:AC&RaccessAmerican College of Rheumatology (ACR)Ankylosing SpondylitisCollinsEULARInternationalPainpatient careQualityRheumatoid arthritisrheumatologist

Related Articles

    Rheum’s Role in the New National Health Service

    April 1, 2007

    What the United States can learn from the U.K. system

    Speak Out Rheum: How the U.K. and U.S. Healthcare Models Stack Up

    May 1, 2013

    A national, socialized medical system has significant advantages over the often-fragmented, unequally distributed U.S. system of healthcare, says one rheumatologist

    Researchers Work Toward Early ID & Treatment of Rheumatoid Arthritis

    September 20, 2018

    AMSTERDAM—Early identification and treatment of rheumatoid arthritis (RA) are two of the most pressing concerns in the field, an expert said at EULAR: the Annual European Congress of Rheumatology. He described the latest efforts to identify patients at risk of RA development and insights on quick referral to rheumatologists. Karim Raza, BM, BCh, PhD, Arthritis…

    Case Report: Adult-Onset Still’s Disease with Complications

    February 14, 2023

    The following report outlines a case of newly diagnosed adult-onset Still’s disease (AOSD) complicated by macrophage activation syndrome (MAS) in a previously healthy and active 32-year-old man who had emigrated from Africa to the U.S. Case A man with no prior medical history presented with acute-onset polyarthritis, fevers and fatigue that began one month previously….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences